Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

NVS
Biotech

Novartis dystrophy data tee up regulatory talks on Avidity drug

Novartis reported a phase 1/2 win for one of the jewels of its Avidity buyout, setting up talks about the next steps for its dystrophy prospect.
Nick Paul Taylor Jun 12, 2026 4:30am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

3 Genentech VPs among those dismissed in latest layoff round

Jun 11, 2026 2:30pm
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
x

Fierce Biotech Layoff Tracker 2026: Genentech, Fulcrum & more

Jun 11, 2026 9:45am
Managing complexity across biopharma modalities

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco
Red heart sewn into white fabric

Kardigan plans to bring in cozy $320M haul from upcoming IPO

Jun 11, 2026 8:14am